je.st
news
Tag: dendreon
UPDATE 2-Valeant to buy bankrupt vaccine maker Dendreon
2015-02-11 03:12:06| Biotech - Topix.net
Valeant Pharmaceuticals International Inc will scoop up bankrupt cancer vaccine maker Dendreon Corp, after no additional qualified bids came forward by Tuesday's deadline, Valeant said. Valeant, of Laval, Quebec, will get Seattle-based Dendreon's Provenge cancer treatment and other assets for $400 million in cash.
Tags: buy
update
maker
vaccine
Valeant raises offer for Dendreon assets to US$400 million to remain lead bidder
2015-02-05 18:29:47| Biotech - Topix.net
Valeant Pharmaceuticals International has raised its offer for the Provenge prostate cancer vaccine and other assets of U.S. drugmaker Dendreon Corp. by $100 million to $400 million. The Quebec-based company is the lead bidder in an auction supervised by a U.S. bankruptcy court.
Tags: offer
lead
million
remain
Skadden, Weil Alum Nab Roles in Dendreon Bankruptcy
2014-11-11 14:18:30| Footwear - Topix.net
In a down year for big corporate bankruptcies, Skadden, Arps, Slate, Meagher & Flom bagged a big assignment Monday for Seattle-based biotechnology company Dendreon as the prostate cancer drug maker filed for Chapter 11 protection in Delaware in a bid to restructure a $620 million debt load. Kenneth Ziman, a deputy head of Skadden's corporate restructuring group in New York, is leading a team from the firm serving as lead debtor's counsel to Dendreon, which will now try to sell itself or its assets in a bankruptcy court in Wilmington.
Tags: weil
roles
bankruptcy
alum
Health Exchange: Merck, Dendreon miss out on health-care rally
2014-11-10 20:44:49| Biotech - Topix.net
Two drug makers on vastly different paths both found themselves in negative territory Monday, as Dow component Merck & Co. Inc. slipped on a disappointing drug trial result and Dendreon Corp. plummeted after filing for bankruptcy.
Tags: health
miss
exchange
healthcare
Mid-Day Market Update: Akorn Shares Slip After Downbeat Outlook; Dendreon Gains
2014-03-03 20:25:10| Jewelry - Topix.net
Midway through trading Monday, the Dow traded down 1.08 percent to 16,145.89 while the NASDAQ tumbled 1.01 percent to 4,264.70.
Tags: market
update
shares
outlook